These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6283568)

  • 21. Alcohol drinking is reduced by a mu 1- but not by a delta-opioid receptor antagonist in alcohol-preferring rats.
    Honkanen A; Vilamo L; Wegelius K; Sarviharju M; Hyytiä P; Korpi ER
    Eur J Pharmacol; 1996 May; 304(1-3):7-13. PubMed ID: 8813578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of tetrahydropapaveroline in the nucleus accumbens and the ventral tegmental area on ethanol preference in the rat.
    Duncan CC; Fernando PW
    Alcohol; 1991; 8(2):87-90. PubMed ID: 2064757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of tetrahydropapaveroline and naltrexone on voluntary ethanol ingestion in rats.
    Oster L; Martinez TT
    Proc West Pharmacol Soc; 1988; 31():277-9. PubMed ID: 3211915
    [No Abstract]   [Full Text] [Related]  

  • 24. Alcohol intake in high alcohol drinking (HAD) rats is suppressed by FG5865, a novel 5-HT1A agonist/5-HT2 antagonist.
    Long TA; Kalmus GW; Björk A; Myers RD
    Pharmacol Biochem Behav; 1996 Jan; 53(1):33-40. PubMed ID: 8848457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alcohol drinking: abnormal intake caused by tetrahydropapaveroline in brain.
    Myers RD; Melchior CL
    Science; 1977 Apr; 196(4289):554-6. PubMed ID: 557839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of alcohol intake by chronic naloxone treatment in P rats: tolerance development and elevation of opiate receptor binding.
    Overstreet DH; Kampov-Polevoy AB; Rezvani AH; Braun C; Bartus RT; Crews FT
    Alcohol Clin Exp Res; 1999 Nov; 23(11):1761-71. PubMed ID: 10591592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of alcohol preference in high alcohol drinking rats: efficacy of amperozide versus naltrexone.
    Myers RD; Lankford MF
    Neuropsychopharmacology; 1996 Feb; 14(2):139-49. PubMed ID: 8822536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyanamide given ICV or systemically to the rat alters subsequent alcohol drinking.
    Critcher EC; Myers RD
    Alcohol; 1987; 4(5):347-53. PubMed ID: 3675855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethanol, salsolinol and tetrahydropapaveroline alter the discharge of neurons in several brain regions: comparison to opioid effects.
    Siggins GR; Berger T; French ED; Shier T; Bloom FE
    Prog Clin Biol Res; 1982; 90():275-87. PubMed ID: 6125947
    [No Abstract]   [Full Text] [Related]  

  • 30. Naloxone decreases ethanol consumption within a free choice paradigm in rats.
    Sandi C; Borrell J; Guaza C
    Pharmacol Biochem Behav; 1988 Jan; 29(1):39-43. PubMed ID: 3353431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naloxone nonselective suppression of drinking of ethanol, sucrose, saccharin, and water by rats.
    Cichelli MJ; Lewis MJ
    Pharmacol Biochem Behav; 2002 Jun; 72(3):699-706. PubMed ID: 12175467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tetrahydroisoquinolines in the brain: the basis of an animal model of alcoholism.
    Myers RD
    Alcohol Clin Exp Res; 1978 Apr; 2(2):145-54. PubMed ID: 350078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bimodal effect of neuropeptide Y on feeding, and its antagonism by receptor blocking agents in rats.
    Borisova EV; Kadar T; Telegdy G
    Acta Physiol Hung; 1991; 78(4):301-8. PubMed ID: 1668706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Naloxone reduces the feeding evoked by intracerebroventricular galanin injection.
    Dube MG; Horvath TL; Leranth C; Kalra PS; Kalra SP
    Physiol Behav; 1994 Oct; 56(4):811-3. PubMed ID: 7528433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of hippocampal lesions produced by intracerebroventricular kainic acid on alcohol drinking in the rat.
    Myers RD; Swartzwelder HS; Holahan W
    Brain Res Bull; 1983 Mar; 10(3):333-8. PubMed ID: 6850361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further studies of opioids and intake of sweetened alcoholic beverage.
    Hubbell CL; Abelson ML; Wild KD; Neuman R; Reid LD
    Alcohol; 1988; 5(2):141-6. PubMed ID: 2840095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of salsolinol and tetrahydropapaveroline with catecholamines.
    Melchior CL
    Alcohol Clin Exp Res; 1979 Oct; 3(4):364-7. PubMed ID: 391089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central action of an inhibitor of brain dopa-decarboxylase, NSD-1015, on cyanamide-induced alcohol drinking in rats.
    Miñano FJ; McMillen BA; Myers RD
    Pharmacol Biochem Behav; 1990 Feb; 35(2):465-8. PubMed ID: 2320657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypericum perforatum CO2 extract and opioid receptor antagonists act synergistically to reduce ethanol intake in alcohol-preferring rats.
    Perfumi M; Santoni M; Cippitelli A; Ciccocioppo R; Froldi R; Massi M
    Alcohol Clin Exp Res; 2003 Oct; 27(10):1554-62. PubMed ID: 14574225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naloxone retards the expression of a genetic predisposition toward alcohol drinking.
    Badia-Elder NE; Mosemiller AK; Elder RL; Froehlich JC
    Psychopharmacology (Berl); 1999 Jun; 144(3):205-12. PubMed ID: 10435386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.